A population model of early rheumatoid arthritis disease activity during treatment with methotrexate sulfasalazine and hydroxychloroquine

机译：甲氨蝶呤柳氮磺吡啶和羟氯喹治疗期间早期类风湿关节炎疾病活动的种群模型

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

AimsTo develop a population model describing the disease activity (DAS28) time course in patients with early rheumatoid arthritis (RA) treated with triple disease-modifying anti-rheumatic drug (DMARD) therapy (methotrexate, sulfasalazine and hydroxychloroquine).

机译：目的建立描述早期风湿性关节炎（RA）患者的疾病活动时间（DAS28）时程的人群模型，该患者使用三病改良抗风湿药（DMARD）治疗（甲氨蝶呤，柳氮磺吡啶和羟氯喹）。

著录项

期刊名称 British Journal of Clinical Pharmacology
作者
Jessica Wojciechowski; Michael D Wiese; Susanna M Proudman; David J R Foster; Richard N Upton;
展开▼
作者单位

展开▼
年(卷),期 2015(79),5
年度 2015
页码 777–788
总页数 12
原文格式 PDF
正文语种
中图分类药学;
关键词
28 Joint Disease Activity Score disease activity disease modifying anti-rheumatic drugs population modelling rheumatoid arthritis;

机译：28关节疾病活动评分;疾病活动;抗风湿药;人群模型;类风湿关节炎;

相似文献

外文文献
中文文献
专利

1. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine [J] . Wojciechowski Jessica, Wiese Michael D., Proudman Susanna M., British Journal of Clinical Pharmacology . 2015,第5期

机译：甲氨蝶呤，柳氮磺吡啶和羟氯喹治疗期间早期类风湿关节炎疾病活动的种群模型
2. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine [J] . Wojciechowski Jessica, Wiese Michael D., Proudman Susanna M., British journal of clinical pharmacology . 2015,第5期

机译：甲氨蝶呤，柳氮磺吡啶和羟氯喹治疗期间早期类风湿关节炎疾病活动的种群模型
3. The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study) [J] . Juan Zhao, Wei Zhou, Yangfeng Wu, BMC Medical Informatics and Decision Making . 2021,第1期

机译：羟基氯喹，磺基甲嘧啶，甲氨蝶呤三重治疗预防风湿性关节炎患者中复发性的疗效，安全性和成本效果，实现临床缓解或低疾病活动：随机对照临床试验的研究方案（护送研究）
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Development and characterization of methotrexate loaded poly(L-lactic acid) microspheres for the treatment of rheumatoid arthritis. [D] . Liang, Sanching Linda. 2006

机译：甲氨蝶呤负载聚（L-乳酸）微球的开发和表征，用于治疗类风湿关节炎。
6. The efficacy safety and cost-effectiveness of hydroxychloroquine sulfasalazine methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study) [O] . Juan Zhao, Wei Zhou, Yangfeng Wu, 2021

机译：羟氯喹苏氟苯胺甲氨蝶呤三重治疗在预防类风湿性关节炎患者中复发的疗效安全性和成本效果以达到临床缓解或低疾病活动：随机对照临床试验的研究方案（护送研究）
7. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine [O] . Wojciechowski, J., Wiese, M., Proudman, S., 2015

机译：甲氨蝶呤，柳氮磺胺吡啶和羟氯喹治疗早期类风湿性关节炎疾病活动的人群模型

A population model of early rheumatoid arthritis disease activity during treatment with methotrexate sulfasalazine and hydroxychloroquine

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅